Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 219,868 | 370,187 | 575,751 | 471,400 | 185,082 |
| Marketable Securities | 1,281,629 | 1,218,406 | 723,295 | 444,473 | 410,269 |
| Other current assets | 40,793 | 33,273 | 29,755 | 18,601 | 15,956 |
| TOTAL | $1,542,290 | $1,621,866 | $1,328,801 | $934,474 | $611,307 |
| Non-Current Assets | |||||
| PPE Net | 20,667 | 16,752 | 15,047 | 14,517 | 13,602 |
| TOTAL | $20,667 | $16,752 | $15,047 | $14,517 | $13,602 |
| Total Assets | $1,563,895 | $1,640,771 | $1,347,425 | $951,474 | $628,555 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $98,018 | $91,333 | $84,212 | $74,955 | $80,680 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $138,936 | $137,391 | $126,389 | $120,575 | $127,791 |
| Shareholders' Equity | |||||
| Retained earnings | -893,066 | -790,810 | -710,412 | -639,619 | -570,764 |
| Other shareholders' equity | 2,318,025 | 2,294,190 | 1,931,448 | 1,470,518 | 1,071,528 |
| TOTAL | $1,424,959 | $1,503,380 | $1,221,036 | $830,899 | $500,764 |
| Total Liabilities And Equity | $1,563,895 | $1,640,771 | $1,347,425 | $951,474 | $628,555 |